Who owns Beam Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BEAM from SEC Form 13F filings across 263 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 263 institutions disclosed 112.2M shares of Beam Therapeutics Inc. worth $2.74B — about 107.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
263
13F holders
$2.74B
value, 2026 filers
107.2%
of shares outstanding (112.2M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BEAM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 12.9M | $316.1M | 0.0% | 12.3% | +2.5% |
| 2 | ARK Investment Management LLC | 11.8M | $288.6M | 1.7% | 11.3% | +15.3% |
| 3 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 10.3M | $251.3M | 1.1% | 9.8% | +0.4% |
| 4 | BlackRock, Inc. | 9.1M | $223.0M | 0.0% | 8.7% | +1.4% |
| 5 | STATE STREET CORP | 5.9M | $144.8M | 0.0% | 5.7% | +1.6% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9M | $119.8M | 0.0% | 4.7% | -0.4% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | $112.7M | 0.0% | 4.4% | +0.2% |
| 8 | ARCH Venture Management, LLC | 4.5M | $111.0M | 6.9% | 4.3% | 0.0% |
| 9 | Kynam Capital Management, LP | 3.9M | $96.2M | 5.3% | 3.8% | +38.5% |
| 10 | Sumitomo Mitsui Trust Group, Inc. | 3.3M | $81.9M | 0.0% | 3.2% | -3.1% |
| 11 | Amova Asset Management Americas, Inc. | 3.3M | $81.8M | 1.0% | 3.2% | -3.1% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $61.5M | 0.0% | 2.4% | -3.2% |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.2M | $53.4M | 0.0% | 2.1% | -36.1% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 2.2M | $53.0M | 0.0% | 2.1% | -2.7% |
| 15 | MORGAN STANLEY | 2.0M | $48.2M | 0.0% | 1.9% | +1.0% |
| 16 | TWO SIGMA INVESTMENTS, LP | 1.6M | $40.1M | 0.0% | 1.6% | +18.2% |
| 17 | Casdin Capital, LLC | 1.5M | $36.7M | 1.6% | 1.4% | +11.1% |
| 18 | GOLDMAN SACHS GROUP INC | 1.3M | $32.8M | 0.0% | 1.3% | +2.4% |
| 19 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.2M | $30.1M | 0.0% | 1.2% | -20.6% |
| 20 | Redmile Group, LLC | 1.1M | $26.0M | 1.9% | 1% | -8.8% |
| 21 | Deep Track Capital, LP | 1.0M | $24.4M | 0.4% | 1% | 0.0% |
| 22 | BNP PARIBAS FINANCIAL MARKETS | 970,033 | $23.7M | 0.0% | 0.9% | -9.2% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 957,836 | $23.4M | 0.0% | 0.9% | +8.1% |
| 24 | NORTHERN TRUST CORP | 912,299 | $22.3M | 0.0% | 0.9% | -2.3% |
| 25 | BAILLIE GIFFORD & CO | 822,960 | $20.1M | 0.0% | 0.8% | +161.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.